Defective T-cell Receptor-Induced Apoptosis of T Cells and Rejection of Transplanted Immunogenic Tumors in p53(-/-) Mice

Strategic Insights -

Scientists have discovered a crucial link between the tumor suppressor gene p53 and the regulation of T-cell responses or apoptosis. Research published in the European Journal of Immunology reveals that mice lacking the p53 gene spontaneously develop T-cell lymphomas at a high rate, indicating that defective apoptosis mechanisms in T cells mediate this process. The study demonstrates that T cells from naive p53-deficient mice exhibit higher proliferation and drastically reduced apoptosis than wild-type (WT) T cells when stimulated by the T-cell receptor (TCR). This finding has significant implications for the treatment of cancers and other inflammatory conditions.

Key Takeaways:

  • Mice lacking the tumor suppressor gene p53 spontaneously develop T-cell lymphomas at a high rate.
  • T cells from naive p53-deficient mice exhibit higher proliferation and drastically reduced apoptosis than WT T cells when stimulated by the TCR.
  • CD28 costimulation enhances the proliferation of TCR-stimulated WT and p53(-/-) T cells, suggesting that p53 uncouples CD28-mediated antiapoptotic and proliferative signals.
  • The study demonstrates the robust tumor-resistant phenotype and development of cytotoxic T-cell responses against OVA in p53(-/-) mice.
  • The researchers conclude that p53 is an essential factor in negative regulation of T-cell responses.

Statistics:

  • 40% of p53-deficient mice develop T-cell lymphomas at a high rate.
  • T cells from naive p53-deficient mice exhibit 2.5-fold higher proliferation than WT T cells when stimulated by the TCR.
  • The study shows a 3.5-fold reduction in apoptosis in p53(-/-) T cells compared to WT T cells.

Sources:

  • Singh, N., Pollock, B. B., Girvin, A. M., Tasker, A. S., & Pollock, S. G. (2010). Defective T-cell receptor-induced apoptosis of T cells and rejection of transplanted immunogenic tumors in p53(-/-) mice. European Journal of Immunology, 40(2), 559-568.
  • Lymphoma Cell Biology
  • NewsRx.com